CONTINUING EDUCATION ACTIVITYNaltrexone: New Dosages and Uses for Pain and InflammationSwidan, Sahar PharmD; Frost, Elizabeth A. M. MD Author Information Dr. Swidan is Director, Professional Programming and Development, American Academy of Anti-Aging Medicine (A4M), Chicago, Illinois; Adjunct Associate Professor of Clinical Research and Leadership, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia; and Adjunct Clinical Associate Professor of Pharmacy, Wayne State University, Detroit, Michigan; 5204 Jackson Road, Suite C, Ann Arbor, MI 48103 E-mail [email protected]; and Dr. Frost is Clinical Professor of Anesthesiology, Icahn School of Medicine at Mount Sinai, New York, New York. Dr. Swiden is a speaker for Amgen and BioHaven. Lippincott CME Institute has identified and mitigated all relevant financial relationships. All other authors, planners, and staff have no relevant financial relationship with any ineligible organizations regarding this educational activity. This activity discusses the off-label use of low-dose naltrexone. CME Accreditation Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 70% of the quiz questions correctly. This CME activity expires on August 31, 2024. NCPD Accreditation Lippincott Professional Development is accredited as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center's Commission on Accreditation. Lippincott Professional Development will award 2.0 contact hours for this NCPD activity. This activity has been assigned 2.0 pharmacology credits. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.0 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, West Virginia, New Mexico, South Carolina, and Florida, CE Broker #50-1223. Your certificate is valid in all states. Instructions for earning ANCC contact hours are included on page 11 of the newsletter. This NCPD activity expires on September 5, 2025. Topics in Pain Management 38(2):p 1-6, September 2022. | DOI: 10.1097/01.TPM.0000872668.35151.10 Buy CE Test Metrics © 2022 Wolters Kluwer Health, Inc. All rights reserved.